Genital Warts (GWs)- Epidemiology Forecast to 2030

Genital Warts (GWs)- Epidemiology Forecast to 2030

  • May 2020 •
  • 102 pages •
  • Report ID: 5897617 •
  • Format: PDF
‘Genital Warts (GWs)- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Genital Warts in the United States.

Geography Covered
• The United States
Study Period: 2017–2030

Genital Warts Disease Understanding
Genital warts (GWs) are transmitted by having sexual contact with someone who already has them, and may be found on the outside of genitals. Some types, which cause cancer, result in the growth of lesions on a woman’s cervix. It is possible to get genital warts, HPV infection, even if they are not visible. They look like flesh-colored bumps that have a cauliflower-like appearance, and are usually flat, papular, or pedunculated growths on the genital mucosa, occurring in clusters. They can appear on the penis, vulva, vagina, cervix, groin, or thigh within weeks or months after sexual contact with an infected person. Potentially cancer-causing HPV strains are spread by sexual intercourse, anal sex, and oral sex. Moreover, genital Warts is also known as anogenital warts (AGWs) or condylomata acuminata.
Genital Warts Epidemiology
The Genital Warts (GWs) epidemiology division provides the insights about historical and current patient pool and forecasted trend the United States. The epidemiology data for Genital Warts are studied through all possible division to give a better understanding about the Disease scenario in the United States. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Genital Warts Epidemiology Segmentation
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (Total Diagnosed Incidence of GWs, Gender-specific Cases, Age-specific Cases of Genital Warts, HPV type associated with GWs and Anatomical Location of Warts) in the United States from 2017–2030.
The report also provides the epidemiology trends observed in the US during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.
According to the report, the total number of diagnosed incident cases of Genital Warts (GWs) in the US was found to be 4,65,000, in the year 2017.

Report Scope

• The report covers detailed overview of Genital Warts explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns

• The report provides the insight about the historical and forecasted patient pool of Genital Warts in the United States

• The Report assesses the disease risk and burden and highlights the unmet needs of the disease

• The Report helps to recognize the growth opportunities in the United States with respect to the patient population

• The report provides the segmentation of the disease epidemiology by Total Diagnosed Incidence of GWs, Gender-specific Cases, Age-specific Cases of Genital Warts, HPV type associated with GWs and Anatomical Location of Warts in the US

Key strengths
• 11 Year Forecast of Genital Warts epidemiology
• The US Coverage
• Total incident cases of GWs
• Incident Cases according to segmentation: Total Diagnosed Incidence of GWs, Gender-specific Cases, Age-specific Cases of Genital Warts, HPV type associated with GWs and Anatomical Location of Warts

Key assessments

• Patient Segmentation
• Disease Risk & Burden

• Risk of disease by the segmentation
• Factors driving growth in a specific patient population